Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Posted on 23/01/202523/01/2025 by Pencis

Prof. Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Prof. Yuan-Biao Qiao, Shanxi University of Chinese Medicine, China

Prof. Yuan-Biao Qiao is a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, Shanxi University of Chinese Medicine, China. He holds a BC degree from Taiyuan University of Science and Technology (1992), an MS from Wuhan University (2005), and a Ph.D. from Qingdao University of Science and Technology (2007). Prof. Qiao completed post-doctoral research at Zhejiang University (2008–2010). With over 20 published research articles and a Shanxi Scientific and Technical Award, his work focuses on innovative drug development and integrating traditional Chinese medicine with modern science.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Yuan-Biao Qiao’s academic journey began with his BC degree from Taiyuan University of Science and Technology in 1992. He furthered his studies at Wuhan University, earning an MS degree in 2005, followed by a Ph.D. from Qingdao University of Science and Technology in 2007. These foundational years highlight his dedication to acquiring a robust academic foundation, enabling him to excel in the field of medicine and traditional Chinese pharmacology.

💼PROFESSIONAL ENDEAVORS:

Prof. Qiao undertook a post-doctoral research stint at Zhejiang University between 2008 and 2010. This critical period allowed him to deepen his expertise, focus on innovative methodologies, and establish a strong presence in the academic and professional communities. Currently, he serves as a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, a role that underscores his leadership and research acumen.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR PHARMACOLOGY:

Prof. Qiao’s primary research revolves around the development of innovative drugs targeting chronic inflammation and serious diseases, bridging traditional Chinese medicine with modern therapeutic approaches. His publication record includes more than 20 research articles, showcasing his commitment to advancing medical knowledge and addressing pressing healthcare challenges.

🌟IMPACT AND INFLUENCE:

Prof. Qiao’s work has earned him the prestigious Shanxi Scientific and Technical Award, a testament to the significance of his contributions. His research not only advances theoretical understanding but also translates into practical solutions, making a tangible impact on the field of medicine and drug development.

📖ACADEMIC CITES AND COLLABORATIONS:

With a consistent record of publishing high-quality research articles, Prof. Qiao has garnered citations and recognition from peers in the scientific community. His collaborative efforts extend to multidisciplinary teams, reflecting his ability to integrate diverse perspectives and foster innovation in research.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Qiao’s ongoing dedication to his field ensures his legacy as a pioneer in integrating traditional Chinese medicine with modern scientific practices. His future endeavors are likely to focus on enhancing the efficacy of therapeutic interventions and contributing to the global recognition of traditional Chinese medicine in treating complex diseases.

🏆CONCLUSION:

Prof. Yuan-Biao Qiao’s extensive academic qualifications, professional expertise, impactful research, and leadership make him a standout candidate for recognition as a Best Researcher. His ability to bridge traditional and modern approaches to medicine exemplifies a legacy of innovation and excellence, ensuring his continued influence in shaping the future of healthcare and science.

TOP NOTABLE PUBLICATIONS

Nrf2/NRF1 signaling activation and crosstalk amplify mitochondrial biogenesis in the treatment of triptolide-induced cardiotoxicity using calycosin

Authors: Qi, X.-M., Zhang, W.-Z., Zuo, Y.-Q., Ren, J.-H., Li, Q.-S.

Journal: Cell Biology and Toxicology

Year: 2025

Herb pair of Huangqi-Danggui exerts anti-tumor immunity to breast cancer by upregulating PIK3R1

Authors: Liu, H.-X., Lian, L., Hou, L.-L., Wen, S.-Y., Li, Q.-S.

Journal: Animal Models and Experimental Medicine

Year: 2024

Methionine redox regulation of actin-interacting proteins primarily governs antioxidative signaling and response to the salvianolic acid B treatment in EA.hy926 cells

Authors: Wang, A.-C., Qi, X.-M., Li, Q.-F., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2024

Bidirectional crosstalk of the cAMP/ROS-dependent signaling pathways in inflammatory macrophage: An activation of formononetin

Authors: Zhang, L.-F., Zhang, X.-Y., Wang, A.-C., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2023

PGC-1α/NRF1-dependent cardiac mitochondrial biogenesis: A druggable pathway of calycosin against triptolide cardiotoxicity

Authors: Qi, X.-M., Qiao, Y.-B., Zhang, Y.-L., Wei, H.-Z., Li, Q.-S.

Journal: Food and Chemical Toxicology

Year: 2023

Improving endothelial cell junction integrity by diphenylmethanone derivatives at oxidative stress: A dual-action directly targeting caveolar caveolin-1

Authors: Zhang, Y.-L., Yuan, H.-X., Sun, J., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2022

GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49

Authors: Ren, J., Wei, H., Sun, J., Xiao, B., Li, Q.

Journal: Frontiers in Pharmacology

Year: 2022

The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway

Authors: Miao, J., Shen, J., Yan, C., Qiao, Y., Li, Q.

Journal: Phytomedicine

Year: 2022

New taraxasterane-type triterpenes from Diaphragma juglandis Fructus

Authors: Tan, J.-Y., Cheng, Y.-G., Li, J.-L., Li, Q.-S., Wang, Y.-L.

Journal: Tetrahedron Letters

Year: 2022

The Chemical Constituents of Diaphragma Juglandis Fructus and Their Inhibitory Effect on α-Glucosidase Activity

Authors: Tan, J., Cheng, Y., Wang, S., Li, Q., Wang, Y.

Journal: Molecules

Year: 2022

Dandan Tian | Hypertension | Best Researcher Award

Posted on 22/01/202522/01/2025 by Pencis

Dr. Dandan Tian | Hypertension | Best Researcher Award

Dr. Dandan Tian, Henan Provincial People’s Hospital, China

Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.

Author Profile

Scopus Profile

EARLY ACADEMIC PURSUITS:

Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.

PROFESSIONAL ENDEAVORS:

Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.

IMPACT AND INFLUENCE:

Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.

ACADEMIC CITES AND RECOGNITION:

Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.

CONCLUSION:

Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.

TOP NOTABLE PUBLICATIONS

Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank

Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.

Journal: IBRO Neuroscience Reports

Year: 2025

Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank

Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.

Journal: Stroke

Year: 2024

Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results

Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.

Journal: Frontiers in Endocrinology

Year: 2024

Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study

Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.

Journal: Frontiers in Cardiovascular Medicine

Year: 2024

Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2023

Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers

Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.

Journal: Pathology and Oncology Research

Year: 2021

Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS

Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.

Journal: Journal of Alloys and Compounds

Year: 2021

Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells

Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2021

Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors

Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.

Journal: Saudi Journal of Biological Sciences

Year: 2017

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on 22/01/202524/01/2025 by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present) and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948

George Matsopoulos | Medical Imaging | Best Researcher Award

Posted on 18/01/202524/01/2025 by Pencis

Prof. George Matsopoulos | Medical Imaging | Best Researcher Award

Prof. George Matsopoulos, National Technical University of Athens, Greece

Prof. George Matsopoulos is a distinguished professor at the National Technical University of Athens, Greece, specializing in biomedical informatics and bioinspired computing. He is the director of the Biomedical Engineering Laboratory and the Laboratory of Biomedical Optics and Applied Biophysics at the university. His research interests encompass medical imaging, biosignal processing, medical decision support systems, and the development of diagnostic technologies using bio-inspired computing. Prof. Matsopoulos has contributed extensively to the field through his academic leadership, research advancements, and involvement in various professional organizations. His work continues to shape the future of healthcare technologies.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

Education:

Prof. George Matsopoulos has a solid educational foundation in electrical and computer engineering and bioengineering. He earned his undergraduate degree from the School of Electrical & Computer Engineering at the National Technical University of Athens (NTUA) from 1983 to 1989. Pursuing advanced studies, he completed an M.Sc. in the Bioengineering Unit at the University of Strathclyde, United Kingdom, in 1989-1990, where he deepened his expertise in biomedical applications. He further advanced his academic journey with a Ph.D. (1990-1993) from the same university, specializing in the Bioengineering Unit and Signal Processing Division, solidifying his expertise in bioengineering and signal processing technologies.

Current Position:

Prof. George Matsopoulos is currently a Professor specializing in “Technologies of Biomedical Informatics and Bioinspired Computing” at the School of Electrical and Computer Engineering, National Technical University of Athens (NTUA), Greece. He is part of the Information Transmission Systems and Material Technology Division, where he leads innovative research and teaching efforts in biomedical informatics and computational systems inspired by biological processes. Based at NTUA’s historic campus at 9, Iroon Polytechniou Street, Athens, he contributes significantly to advancing interdisciplinary research and fostering academic excellence. His role reflects his dedication to integrating engineering principles with cutting-edge biomedical technologies.

Research Experience:

Prof. George Matsopoulos has extensive research experience spanning over three decades, contributing significantly to biomedical engineering and related fields. Since 2022, he has served as the Director of the Biomedical Engineering Laboratory at the National Technical University of Athens (NTUA). He also leads the Laboratory of Biomedical Optics and Applied Biophysics, a role he has held since 2016. His academic progression at NTUA includes appointments as Professor (2018-present), Associate Professor (2014-2018), and Assistant Professor (2008-2014) in “Technologies of Biomedical Informatics and Bioinspired Computing.” Previously, he held research positions at the Microwave and Fiber Optics Laboratory and the University of Strathclyde.

Professional Experience:

Prof. George Matsopoulos has a distinguished professional career, including roles in academia, industry, and leadership. He is an elected Fellow of the European Alliance of Medical and Biological Engineering and Science (EAMBES) and the International Academy of Medical and Biological Engineers (IAMBE) and a Senior Member of IEEE (2024-present). He serves on the IEEE Journal of Biomedical and Health Informatics editorial team and the IEEE EMBS Greek Chapter Management Committee. He has held leadership roles, including President of the Rizareio Foundation and Vice President of the National Documentation Centre. Additionally, he consults for European and national programs, specializing in biomedical technology procurement and applications.

Research Interests:

Prof. George Matsopoulos’s research interests include medical imaging, biosignal processing (e.g., EEG, ECG), multidimensional medical data fusion, digital medical image and signal processing, and bio-inspired diagnostic systems. He also focuses on medical decision support systems, biological modeling, telemedicine, mobile health, PACS, and medical information systems for enhanced healthcare delivery.

Awards and Honors:

Prof. George Matsopoulos has received numerous prestigious awards and honors throughout his career, recognizing his contributions to biomedical engineering and informatics. He was elected as a Fellow of the European Alliance of Medical and Biological Engineering and Science (EAMBES) and the International Academy of Medical and Biological Engineers (IAMBE) in 2024, reflecting his significant impact on the field. As a Senior Member of IEEE, he is acknowledged for his professional excellence and contributions to engineering. Additionally, his leadership and innovation in interdisciplinary postgraduate programs and biomedical technology have earned him recognition on national and international platforms, further solidifying his esteemed reputation.

Citations:

Citations – 4339
h-index – 32
i10-index – 93

Conclusion:

Prof. George Matsopoulos is a distinguished academic and researcher with extensive expertise in biomedical informatics, bioengineering, and medical technologies. His innovative work in medical imaging, biosignal processing, and the development of advanced medical decision support systems has significantly contributed to the field. Prof. Matsopoulos’s focus on bio-inspired computing, telemedicine, and the creation of integrated healthcare systems further underscores his commitment to advancing healthcare technologies. Through his leadership in various research laboratories and active participation in professional organizations, he continues to make impactful contributions to both academia and the broader medical community.

Top Notable Publications

Article: Exploring New Tools in Upper Limb Rehabilitation After Stroke Using an Exoskeletal Aid: A Pilot Randomized Control Study

Authors: Syringas, P., Potsika, V., Tachos, N., Matsopoulos, G.K., Fotiadis, D.I.

Journal: Healthcare (Switzerland)

Year: 2025

Article: The Styloid Process Length and the Stylohyoid Chain Ossification Affect Its Relationship with the Carotid Arteries

Authors: Triantafyllou, G., Botis, G., Vassiou, K., Matsopoulos, G., Piagkou, M.

Journal: Annals of Anatomy

Year: 2025

Article: Automatic Segmentation in 3D CT Images: A Comparative Study of Deep Learning Architectures for the Automatic Segmentation of the Abdominal Aorta

Authors: Mavridis, C., Vagenas, T.P., Economopoulos, T.L., Kakkos, I., Matsopoulos, G.K.

Journal: Electronics (Switzerland)

Year: 2024

Article: Sex Estimation Through Orbital Measurements: A Machine Learning Approach for Forensic Science

Authors: Triantafyllou, G., Botis, G.G., Piagkou, M., Matsopoulos, G.K., Papadodima, S.

Journal: Diagnostics

Year: 2024

Article: Hand Dexterities Assessment in Stroke Patients Based on Augmented Reality and Machine Learning Through a Box and Block Test

Authors: Papagiannis, G., Triantafyllou, A., Yiannopoulou, K.G., Tachos, N., Fotiadis, D.I.

Journal: Scientific Reports

Year: 2024

Article: Multi-Graph Assessment of Temporal and Extratemporal Lobe Epilepsy in Resting-State fMRI

Authors: Amoiridou, D., Gkiatis, K., Kakkos, I., Garganis, K., Matsopoulos, G.K.

Journal: Applied Sciences (Switzerland)

Year: 2024

Article: A Multidimensional Framework Incorporating 2D U-Net and 3D Attention U-Net for the Segmentation of Organs from 3D Fluorodeoxyglucose-Positron Emission Tomography Images

Authors: Vezakis, A., Vezakis, I., Vagenas, T.P., Kakkos, I., Matsopoulos, G.K.

Journal: Electronics (Switzerland)

Year: 2024

Article: Enhancing Sports Injury Risk Assessment in Soccer Through Machine Learning and Training Load Analysis

Authors: Tsilimigkras, T., Kakkos, I., Matsopoulos, G.K., Bogdanis, G.C.

Journal: Journal of Sports Science and Medicine

Year: 2024

Article: ProLesA-Net: A Multi-Channel 3D Architecture for Prostate MRI Lesion Segmentation with Multi-Scale Channel and Spatial Attentions

Authors: Zaridis, D.I., Mylona, E., Tsiknakis, N., Tsiknakis, M., Fotiadis, D.I.

Journal: Patterns

Year: 2024

Article: ResQu-Net: Effective Prostate’s Peripheral Zone Segmentation Leveraging the Representational Power of Attention-Based Mechanisms

Authors: Zaridis, D.I., Mylona, E., Tachos, N., Koutsouris, D.D., Fotiadis, D.I.

Journal: Biomedical Signal Processing and Control

Year: 2024

Mengchao Wei | Venous thromboembolism | Best Researcher Award

Posted on 10/01/202510/01/2025 by Pencis

Dr. Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei, Peking Union Medical College Hospital, China

Dr. Mengchao Wei is a physician at Peking Union Medical College Hospital, China, specializing in Urology. He graduated with a Doctor’s degree from Sun Yat-sen University in 2019. Since joining PUMCH in 2021, Dr. Wei has focused on optimizing perioperative management for urologic surgeries. He developed a predictive model for venous thromboembolism risk post-surgery, now integrated into clinical practice. Dr. Wei has published 10 journal articles in SCI and Scopus indexed journals. His research aims to improve patient safety and surgical outcomes, making significant contributions to the field of urologic surgery.

Author Profile

Orcid Profile

📚Early Academic Pursuits:

Dr. Mengchao Wei graduated with a Doctor’s degree from Sun Yat-sen University in 2019. His academic journey laid the foundation for his current work, particularly in the field of Urology, where he became deeply involved in understanding the nuances of perioperative management in urologic surgeries. His comprehensive training and early research set him on a path to clinical excellence and innovation.

⚕️Professional Endeavors and Contributions:

Since 2021, Dr. Wei has been practicing as a Physician at Peking Union Medical College Hospital, where his focus lies in the optimization of perioperative management in urologic surgeries. His clinical work has had a direct impact on improving patient care and the efficiency of surgical outcomes. Dr. Wei’s contributions include the development of a predictive model for venous thromboembolism risk following urologic surgeries, which has been implemented in real-world clinical practice to enhance patient safety.

🔬Research Focus and Innovations on Venous thromboembolism:

Dr. Wei’s research centers on perioperative management within urology, particularly concerning venous thromboembolism (VTE) risk. His predictive model for VTE risk, now utilized in clinical settings, showcases his ability to translate research into tangible, life-saving outcomes. While his citation index stands at 10, his work continues to gain attention in the medical community. He has published 10 journals in esteemed databases such as SCI and Scopus, reinforcing his status as a respected figure in urologic research.

🌍Impact and Influence:

Dr. Wei’s contributions have not only benefited his hospital but also shaped the way urologic surgeries are managed perioperatively. By providing a tool that enhances clinical decision-making, he directly improves surgical outcomes, patient safety, and overall healthcare efficiency. His work has influenced peers, setting a new standard in the field of urology.

📑Academic Citations:

Dr. Wei has an impressive citation index of 10, a reflection of the growing recognition of his work and the clinical value it brings. His research continues to receive acknowledgment in relevant medical journals, contributing to the advancement of perioperative care in urology.

🚀Legacy and Future Contributions:

Dr. Wei’s research and innovations indicate a promising future in the field of urology. He is committed to enhancing perioperative management for urologic surgeries and advancing clinical practices. Moving forward, his aim is to refine predictive models and further contribute to patient safety and surgical excellence.

🌟Conclusion:

Dr. Mengchao Wei’s work at Peking Union Medical College Hospital has made a significant impact on perioperative management in urologic surgeries. His predictive model for venous thromboembolism risk has been successfully integrated into clinical practice, improving patient outcomes and safety. With 10 journal publications in SCI and Scopus indexed journals, Dr. Wei is recognized as a dedicated and innovative physician. His contributions are shaping the future of urologic surgery. As he continues to push the boundaries of medical research, his work promises to enhance the quality of care and patient safety worldwide.

Top Notable Publications

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

Authors: Mengchao Wei

Journal: Scientific Reports

Year: 2025

The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma

Authors: Mengchao Wei

Journal: BMC Urology

Year: 2024

Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial

Authors: Mengchao Wei

Journal: World Journal of Urology

Year: 2024

Surgery or external beam radiation for solitary small hepatocellular carcinoma

Authors: Mengchao Wei

Journal: Journal of Cancer Research and Therapeutics

Year: 2023

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

Authors: Mengchao Wei

Journal: Frontiers in Oncology

Year: 2022

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2022

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer

Authors: Mengchao Wei

Journal: International Journal of Radiation Oncology, Biology, Physics

Year: 2022

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2020

Radiofrequency ablation plus nucleotide analogues for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis

Authors: Mengchao Wei

Journal: American Journal of Translational Research

Year: 2018

Sorafenib versus Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Authors: Mengchao Wei

Journal: BMC Cancer

Year: 2018

xie zhengxing | Cardiovascular Disease | Best Research Article Award

Posted on 08/01/202508/01/2025 by Pencis

Prof. xie zhengxing | Cardiovascular Disease | Best Research Article Award

Prof. xie zhengxing, Department of neurosurgery the Affiliaged Hospital of Jiangsu University, China

Prof. Xie Zhengxing is the Director of the Department of Neurosurgery at The Affiliated Hospital of Jiangsu University, China. A distinguished neurosurgeon with a Ph.D. degree, he specializes in neuroendoscopic surgery and minimally invasive neurosurgery. Prof. Xie also serves as the Chief Director of the Neurosurgical Branch of the Medical Association of Zhenjiang City and is a member of the Neurosurgical Branch of the Medical Association of Jiangsu Province. His work focuses on advancing innovative surgical techniques and improving patient outcomes, making him a leading figure in the field of neurosurgery.

Author Profile

Orcid Profile

EARLY ACADEMIC PURSUITS:

Professor Xie Zhengxing embarked on a path of excellence early in his academic career. His dedication to the medical sciences culminated in earning a Ph.D. degree, which laid the foundation for his remarkable journey in neurosurgery. His rigorous training and pursuit of knowledge equipped him with the expertise needed to address complex challenges in the field of neuroscience.

PROFESSIONAL ENDEAVORS:

Currently serving as the Director of the Department of Neurosurgery at The Affiliated Hospital of Jiangsu University, Professor Xie Zhengxing has been a cornerstone of innovation and leadership in the medical community. He holds the position of Chief Director of the Neurosurgical Branch of the Medical Association of Zhenjiang City and is an active member of the Neurosurgical Branch of the Medical Association of Jiangsu Province. These roles underscore his professional stature and his dedication to advancing neurosurgery at both city and provincial levels.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASE:

Professor Xie specializes in neuroendoscopic surgery and minimally invasive neurosurgery, two cutting-edge fields that emphasize precision and improved patient recovery times. His research has pushed the boundaries of traditional neurosurgical approaches, integrating advanced technologies to enhance the efficacy and safety of procedures. His focus on minimally invasive techniques demonstrates his commitment to reducing patient trauma and improving surgical outcomes.

IMPACT AND INFLUENCE:

Professor Xie Zhengxing’s work has had a profound impact on the field of neurosurgery. His innovative approaches to treatment and surgical techniques have set new standards in patient care. As a leader in his department and various medical associations, he has been instrumental in fostering collaboration among professionals, enhancing neurosurgical practices, and inspiring younger generations of medical practitioners.

ACADEMIC CITATIONS:

With numerous academic publications to his name, Professor Xie’s research is frequently cited in peer-reviewed journals, reflecting the significance of his contributions to the medical community. His work not only advances scientific understanding but also serves as a reference point for neurosurgeons and researchers worldwide.

LEGACY AND FUTURE CONTRIBUTIONS:

Professor Xie’s legacy lies in his dual commitment to clinical excellence and academic rigor. As a mentor, he has nurtured the growth of aspiring neurosurgeons, ensuring the sustainability of high standards in the field. Moving forward, his focus on integrating emerging technologies with traditional neurosurgery promises to further revolutionize patient care and inspire future innovations.

OTHER IMPORTANT HIGHLIGHTS:

Awards and Recognitions: Professor Xie has likely received accolades for his clinical and research achievements, further cementing his status as a leading figure in neurosurgery.
Educational Outreach: Through his roles in medical associations, he has played a vital part in organizing workshops, conferences, and training sessions for practitioners.
Global Influence: His contributions have likely attracted international attention, establishing him as a thought leader in minimally invasive neurosurgical techniques.

CONCLUSION:

Professor Xie Zhengxing is a trailblazer in neurosurgery, renowned for his expertise in neuroendoscopic and minimally invasive techniques. As the Director of the Department of Neurosurgery at The Affiliated Hospital of Jiangsu University, he has significantly advanced patient care and surgical practices. His leadership roles in medical associations highlight his commitment to fostering collaboration and innovation in the field. With impactful research and a dedication to mentoring future neurosurgeons, Professor Xie’s contributions extend far beyond his clinical work. His enduring influence continues to shape the future of neurosurgery, cementing his legacy as a pioneer and leader in the discipline.

TOP NOTABLE PUBLICATIONS

Clipping Aneurysms via a Fully Endoscopic Transcranial Approach

Authors: Zhengxing Xie

Journal: Scientific Reports

Year: 2024

Fully Endoscopic Neurosurgery Using a Two-Handed Technique for Cerebellopontine Angle Tumors via the Retrosigmoid Approach

Authors: Zhengxing Xie, Yan Zhuang, Jieping Liu

Journal: Frontiers in Oncology

Year: 2024

Xiaodong Jiang | Critical Care Medicine | Best Researcher Award

Posted on 03/01/202503/01/2025 by Pencis

Mr. Xiaodong Jiang | Critical Care Medicine | Best Researcher Award

Mr. Xiaodong Jiang, Second Affiliated Hospital of Dalian Medical University, China

Mr. Xiaodong Jiang is a Chief Physician and Doctoral Researcher in Critical Care Medicine at the Second Affiliated Hospital of Dalian Medical University, China. As Deputy Director of the Critical Care Medicine Department, he excels in ECMO techniques and the management of severe and complex critical conditions. He is also a Master’s Supervisor, Party Branch Secretary, and Deputy Director of the Critical Care Medicine Teaching and Research Office. Actively involved in national and regional medical committees, he contributes to advancing critical care practices and education. His work in clinical innovation and academic leadership establishes him as a prominent expert in critical care medicine.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Mr. Jiang Xiaodong embarked on his academic journey with a clear focus on critical care medicine, quickly distinguishing himself as a dedicated scholar. His early studies laid the foundation for his expertise in managing life-threatening conditions, paving the way for his role as a Chief Physician and Doctoral Researcher. His academic excellence and commitment to learning were evident as he advanced through rigorous medical training and specialized in critical care medicine.

🩺PROFESSIONAL ENDEAVORS:

Mr. Jiang serves as the Deputy Director of the Critical Care Medicine Department and Deputy Director of the Critical Care Medicine Teaching and Research Office at the Second Affiliated Hospital of Dalian Medical University. In these roles, he combines clinical expertise with administrative responsibilities, ensuring the seamless functioning of critical care units and fostering innovation in patient care.

Additionally, as the Secretary of the Critical Care Medicine Party Branch, he demonstrates exemplary leadership, influencing policies and practices within the hospital’s critical care division.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CRITICAL CARE MEDICINE:

Mr. Jiang’s research focus includes groundbreaking work in ECMO (Extracorporeal Membrane Oxygenation) treatment techniques, such as VV-ECMO, VA-ECMO, and ECPR. His expertise has revolutionized the management of severe pneumonia, emergency PCI, and perioperative care for lung transplants.

His contributions extend to the development of advanced rescue strategies for critical conditions, solidifying his status as a leading innovator in critical care medicine. His research findings have practical applications, improving patient survival rates and recovery outcomes.

🌟IMPACT AND INFLUENCE

Through his academic and professional positions, Mr. Jiang has significantly influenced critical care medicine at both regional and national levels. His active membership in various medical committees, including the Chinese Medical Doctor Association and Liaoning Medical Association, highlights his role in shaping critical care policies and advancing best practices.

His leadership extends to academic and clinical education, mentoring young professionals, and fostering the next generation of critical care specialists.

📝ACADEMIC CITES AND EDITORIAL CONTRIBUTIONS:

Mr. Jiang is a recognized authority in his field, serving as an invited reviewer for prestigious journals, including the Chinese Journal of Emergency Medicine and the Chinese Journal of Critical Care Medicine.

As an Editorial Board Member of the Chinese Journal of Postgraduate Medical Education, he ensures the dissemination of high-impact research, further enhancing the academic landscape of critical care medicine.

🌍LEGACY AND FUTURE CONTRIBUTIONS:

Mr. Jiang’s legacy is defined by his unwavering commitment to advancing critical care medicine. His work in ECMO techniques, patient-centered care, and innovative research sets a benchmark for excellence.

Looking to the future, Mr. Jiang is poised to continue his groundbreaking research and expand his influence, leaving an indelible mark on critical care medicine. His dedication inspires colleagues and students alike, ensuring that his contributions will resonate for years to come.

🏆FINAL REMARKS AND RECOGNITION:

Mr. Jiang Xiaodong embodies the qualities of a distinguished researcher, clinician, and academic leader. His comprehensive achievements in critical care medicine make him a deserving candidate for any accolade recognizing excellence and innovation in medical science. Recognizing his contributions will not only honor his work but also inspire continued progress in the field of critical care medicine.

🌟CONCLUSION:

Mr. Xiaodong Jiang stands as a beacon of excellence in critical care medicine, seamlessly blending clinical expertise, academic leadership, and innovative research. His groundbreaking work in ECMO techniques and dedication to improving patient outcomes have set new standards in the field. Through his roles in education and professional organizations, he continues to inspire the next generation of medical professionals.

With his unwavering commitment to advancing critical care practices, Mr. Jiang’s contributions will leave a lasting impact on the medical community. He is a true leader and innovator, deserving of recognition and admiration.

TOP NOTABLE PUBLICATIONS:

Machine learning for predicting acute myocardial infarction in patients with sepsis

Authors: Fang, S., Jin, H., Zhang, J., Su, W., Jiang, X.

Journal: Scientific Reports

Year: 2024

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

Authors: Gong, D., Yu, J., Jiang, X.

Journal: Frontiers in Oncology

Year: 2022

Effect of MIR-26a targeting GSK-3β/β-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion

Authors: Gong, D.-D., Yu, J., Yu, J.-C., Jiang, X.-D.

Journal: European Review for Medical and Pharmacological Sciences

Year: 2019

Takotsubo-like cardiomyopathy in a giant pheochromocytoma

Authors: Zhu, D., Yu, J., Li, X., Jiang, X., Zhuang, C.

Journal: International Journal of Cardiology

Year: 2014

Quan Yuan | Cardiovascular| Best Researcher Award

Posted on 31/12/202431/12/2024 by Pencis

Prof. Quan Yuan | Cardiovascular | Best Researcher Award

Prof. QuanYuan, Wuhan University, China

Professor Quan Yuan, a distinguished researcher at Wuhan University, specializes in analytical chemistry with a focus on developing innovative methods for complex sample analysis. His pioneering work includes creating high-sensitivity field-effect transistor-based biosensors for the detection of myocardial injury biomarkers, significantly advancing rapid and accurate heart disease diagnosis. With over 139 journal publications, an H-Index of 41, more than 6,070 citations, 9 patents, and 2 authored books, Professor Yuan’s contributions are widely recognized. As Deputy Editor of “Sensors & Diagnostics” and a key member of multiple professional committees, he exemplifies excellence in research, leadership, and scientific innovation.

Author Profile

Orcid Profile

Education:

Professor Quan Yuan has an outstanding educational background that has shaped his career in analytical chemistry and biosensor technology. He earned his undergraduate degree in Chemistry from a prestigious institution in China, where he developed a strong foundation in chemical principles and experimental techniques. He pursued his master’s degree, specializing in analytical methods, which laid the groundwork for his innovative research. Professor Yuan completed his Ph.D. in Analytical Chemistry, focusing on advanced biosensor development for medical applications. His academic journey reflects a commitment to excellence, equipping him with the expertise to contribute significantly to science, innovation, and education.

Professional Experience:

Professor Quan Yuan has extensive professional experience in both academia and industry. He has led multiple research projects, including the development of highly sensitive biosensors for myocardial injury biomarkers, which have advanced clinical diagnostic methods. As a Deputy Editor for prominent journals such as Sensors & Diagnostics and Chinese Journal of Chemistry, he actively contributes to the scientific community. Professor Yuan has collaborated on various consultancy projects and has worked with leading organizations to translate his research into practical applications. His contributions span across over 6,000 citations and numerous patents, solidifying his reputation as a leading figure in his field.

Research skills:

Professor Quan Yuan possesses exceptional research skills in analytical chemistry and biosensor development. His expertise lies in designing high-sensitivity detection methods, particularly for complex samples such as body fluids and tissues. He has developed a field-effect transistor-based biosensor capable of detecting multiple myocardial injury biomarkers, using advanced machine learning algorithms for risk assessment and prognosis monitoring. His proficiency in integrating circuit technology with biosensors has led to the creation of a portable analysis system for rapid clinical diagnostics. Professor Yuan’s skills in both experimental design and data interpretation, alongside his interdisciplinary approach, have significantly impacted the medical diagnostics field.

Awards and Honors:

Professor Quan Yuan has received numerous awards and honors in recognition of his groundbreaking contributions to analytical chemistry and biomedical diagnostics. His research has earned him significant recognition in the scientific community, including over 6,070 citations and an H-Index of 41. He holds 9 patents and has published extensively in prestigious journals. In addition to his research achievements, Professor Yuan serves as Deputy Editor for “Sensors & Diagnostics” and the “Chinese Journal of Chemistry.” He is actively involved in several professional committees, including the Chinese Chemical Society and the China Medical Equipment Association, showcasing his leadership in advancing scientific innovation.

Conclusion:

Professor Quan Yuan’s exceptional research and groundbreaking innovations in analytical chemistry, particularly in the development of advanced biosensors for heart disease diagnosis, make him a highly deserving candidate for the Best Researcher Award. His pioneering work has not only advanced scientific understanding but also led to practical applications in clinical diagnostics, improving patient care. With a remarkable publication record, numerous patents, and influential roles in editorial and professional committees, Professor Yuan’s leadership in both research and academia has significantly impacted the field. His ongoing contributions continue to shape the future of medical diagnostics and scientific innovation.

Top Notable Publications

Persistent luminescence encoding for rapid and accurate oral-derived bacteria identification

Authors: Not provided

Journal: Chinese Chemical Letters

Year: 2025

Staggered-Stacking Two-Dimensional Covalent Organic Framework Membranes for Molecular and Ionic Sieving

Authors: Not provided

Journal: ACS Nano

Year: 2024

Bio‐Inspired Multiple Responsive NIR II Nanophosphors for Reversible and Environment‐Interactive Information Encryption

Authors: Not provided

Journal: Advanced Materials

Year: 2024

Framework nucleic acid strategy enables closer microbial contact for programming short-range interaction

Authors: Not provided

Journal: Science Advances

Year: 2024

Defect Regulation Strategy of Porous Persistent Phosphors for Multiple and Dynamic Information Encryption

Authors: Not provided

Journal: Small Methods

Year: 2024

DNA Nanomaterial-Based Electrochemical Biosensors for Clinical Diagnosis

Authors: Not provided

Journal: ACS Nano

Year: 2024

Smart Persistent Luminescence Imaging for Early Diagnosis of Drug-Induced Liver Injury

Authors: Not provided

Journal: Chemical & Biomedical Imaging

Year: 2024

Thermodynamics and Kinetics‐Directed Regulation of Nucleic Acid‐Based Molecular Recognition

Authors: Not provided

Journal: Small Methods

Year: 2024

Bionic Potassium Ion Channel in Live Cells Repairs Cardiomyocyte Function

Authors: Not provided

Journal: Journal of the American Chemical Society

Year: 2024

Self‐Powered and Self‐Recoverable Multimodal Force Sensors Based on Trap State and Interfacial Electron Transfer

Authors: Not provided

Journal: Angewandte Chemie International Edition / Angewandte Chemie

Year: 2024

Menghua Xiong | Nanomedicine | Best Researcher Award

Posted on 28/12/202428/12/2024 by Pencis

Prof. Menghua Xiong | Nanomedicine | Best Researcher Award

Prof. Menghua Xiong, South China University of Technology, China

Prof. Menghua Xiong is a professor at the School of Biomedical Sciences and Engineering at South China University of Technology, Guangzhou, China. He earned his B.E. and Ph.D. in Polymer Science and Engineering from the University of Science and Technology of China (USTC), where he worked under the mentorship of Prof. Jun Wang. Prof. Xiong completed postdoctoral research at the University of Illinois at Urbana-Champaign in the Department of Materials Science and Engineering, working with Prof. Jianjun Cheng. His research focuses on advanced polymers, drug delivery systems, and biomedical materials, contributing significantly to the development of novel materials for medical applications.

Author Profile

Orcid Profile

Google Scholar

🎓EARLY ACADEMIC PURSUITS:

Prof. Menghua Xiong began his academic journey in September 2003 at the University of Science and Technology of China (USTC), where he earned his Bachelor of Engineering (B.E.) degree in Polymer Science and Engineering in July 2007. He continued his studies at USTC, completing a Ph.D. in Polymer Science and Engineering under the guidance of Prof. Jun Wang from September 2007 to June 2013.

🏫PROFESSIONAL ENDEAVORS:

After completing his doctoral studies, Prof. Xiong pursued postdoctoral research at the University of Illinois at Urbana-Champaign (UIUC) from July 2013 to December 2017. During this period, he worked in the Department of Materials Science and Engineering under the mentorship of Prof. Jianjun Cheng, gaining valuable experience in materials science and engineering. In January 2018, Prof. Xiong joined the School of Biomedical Sciences and Engineering at the Guangzhou International Campus of South China University of Technology as a professor, where he currently holds a faculty position.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE:

Prof. Xiong’s research focuses on polymer science and biomedical engineering, with significant contributions to the development of advanced materials for biomedical applications. His work spans areas such as the synthesis and design of novel polymers, drug delivery systems, and biomaterials for medical use. He has made noteworthy advancements in the intersection of materials science, biomedical engineering, and polymer chemistry.

📈IMPACT AND INFLUENCE:

Prof. Xiong has been influential in the field of polymer science and biomedical engineering, contributing to key developments in the design of functional materials for drug delivery and tissue engineering. His research has led to innovations that have applications in the medical field, impacting drug delivery systems and materials used in medical devices. He is also known for his collaborations with international researchers and for mentoring future scientists in the field.

📚ACADEMIC CITATIONS:

Prof. Xiong has received recognition for his research in terms of academic citations, with his work being referenced by researchers in polymer science, materials engineering, and biomedical fields. His publications have contributed to the advancement of knowledge in areas such as polymer synthesis, biomedical materials, and drug delivery technologies.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Xiong’s legacy is marked by his dedication to advancing the field of polymer science and biomedical engineering. His future contributions are expected to focus on further innovations in biomaterials, particularly in areas like personalized medicine, advanced drug delivery systems, and tissue engineering. As a mentor and researcher, Prof. Xiong continues to influence the development of the next generation of scientists and researchers in these fields.

🌍CONCLUSION:

Prof. Menghua Xiong is a prominent figure in the fields of polymer science and biomedical engineering, with a strong academic foundation from the University of Science and Technology of China (USTC) and valuable postdoctoral experience at the University of Illinois at Urbana-Champaign. His research contributions, particularly in the areas of polymer synthesis, drug delivery, and biomedical materials, have made a significant impact on advancing medical technologies. As a professor at South China University of Technology, Prof. Xiong continues to shape the future of biomedical sciences through his innovative work and mentorship of the next generation of researchers.

CITATIONS:

Citations – 4286
h-index – 27
i10-index – 29

TOP NOTABLE PUBLICATIONS

The Relationship between In Vivo Toxicity and Responsive pH in Transistor‐Like pH‐Sensitive Nanodetergents

Authors: Meng-Hua Xiong

Journal: Small Methods

Year: 2024

Helicity-directed recognition of bacterial phospholipid via radially amphiphilic antimicrobial peptides

Authors: Meng-Hua Xiong

Journal: Science Advances

Year: 2024

Stimuli‐responsive linkers and their application in molecular imaging

Authors: Meng-Hua Xiong

Journal: Exploration

Year: 2024

Stimuli-responsive linkers and their application in molecular imaging (Preprint)

Authors: Meng-Hua Xiong

Journal: Exploration (Preprint)

Year: 2023

pH Window for High Selectivity of Ionizable Antimicrobial Polymers toward Bacteria

Authors: Meng-Hua Xiong

Journal: ACS Applied Materials & Interfaces

Year: 2023

A helical oncolytic polypeptide with potent membranolytic activity for cancer therapy

Authors: Meng-Hua Xiong

Journal: Biomaterials Science

Year: 2023

Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancer

Authors: Meng-Hua Xiong

Journal: Theranostics

Year: 2023

A transistor-like pH-sensitive nanodetergent for selective cancer therapy

Authors: Meng-Hua Xiong

Journal: Nature Nanotechnology

Year: 2022

Biomedical polymers: synthesis, properties, and applications

Authors: Meng-Hua Xiong

Journal: Science China Chemistry

Year: 2022

Modulation of Conformational Transition of Polypeptides under Slightly Acidic Environment

Authors: Meng-Hua Xiong

Journal: Chinese Journal of Chemistry

Year: 2022

Qian-Qian chen | Pharmacology | Best Researcher Award

Posted on 26/12/202426/12/2024 by Pencis

Prof. Qian-Qian chen | Pharmacology | Best Researcher Award

Prof. Qian-Qian chen, Nanjing University of Chinese Medicine, China

Prof. Qian-Qian Chen is an Associate Professor at the School of Pharmacy at Nanjing University of Chinese Medicine, China. He holds a Ph.D. in Pharmacognosy from China Pharmaceutical University, Nanjing. His research focuses on the molecular mechanisms of cardiovascular and renal diseases, the regulatory effects of traditional Chinese medicine (TCM) on disease progression, and the role of the neuraminidase protein family in chronic conditions. Prof. Chen has published extensively in high-impact journals such as Advanced Science, Nature Communications, and European Heart Journal. He is committed to advancing both modern pharmacology and TCM in the context of chronic diseases.

Author Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Qian-Qian Chen began his academic journey with a Bachelor of Science in Pharmacy from Beihua University, Jilin, China, graduating in June 2015. Demonstrating exceptional academic potential, he pursued a Master’s degree in Pharmacy at China Pharmaceutical University, Nanjing, China, from September 2015 to July 2018. He further refined his expertise by completing a Ph.D. in Pharmacognosy at the same university, achieving his doctorate in July 2021.

🏫PROFESSIONAL ENDEAVORS:

Currently serving as an Associate Professor and Master’s Supervisor in Pharmacology at the School of Pharmacy, Nanjing University of Chinese Medicine, Prof. Chen has been in this role since March 2022. His teaching and mentorship significantly contribute to nurturing the next generation of researchers in pharmacology and traditional Chinese medicine (TCM).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Pharmacology:

Prof. Chen’s research is primarily centered around the molecular mechanisms underlying cardiovascular and renal diseases. His work focuses on three major areas:
1️⃣ Exploring the molecular pathways involved in cardiovascular and renal disease progression.
2️⃣ Investigating the regulatory effects of traditional Chinese medicine (TCM) on these diseases.
3️⃣ Unveiling the roles and mechanisms of the neuraminidase protein family in chronic conditions, including ventricular remodeling and chronic kidney injury.

His dedication to these fields has yielded a wealth of insights that advance understanding and treatment strategies for complex cardiorenal syndromes.

📈IMPACT AND INFLUENCE:

Prof. Chen has made significant contributions to the scientific community through his publications in prestigious journals. These include:

Advanced Science (2024)
Nature Communications (2023)
European Heart Journal (2021)
Journal of Ethnopharmacology (2021)
The American Journal of Chinese Medicine (2021)
Circulation (2018)

His groundbreaking studies on cardiovascular and renal diseases have been highly cited and praised for their clinical relevance and innovative methodologies.

📚ACADEMIC CITES AND LEGACY:

Prof. Chen’s published work has been widely referenced in the fields of pharmacology, traditional Chinese medicine, and chronic disease research. His studies, particularly those addressing the interplay between cardiovascular and renal systems, serve as a cornerstone for researchers exploring related domains.

🌟FUTURE CONTRIBUTIONS AND VISION:

Looking ahead, Prof. Chen aims to:

Expand the understanding of traditional Chinese medicine’s regulatory roles in disease mechanisms.
Advance therapeutic strategies for chronic diseases through interdisciplinary research.
Mentor emerging researchers, fostering innovation and excellence in pharmacological sciences.

His commitment to merging modern scientific techniques with traditional medicine holds the promise of revolutionary breakthroughs in healthcare.

🌍CONCLUSION:

Prof. Qian-Qian Chen’s impressive academic trajectory, impactful research, and dedication to advancing pharmacology place him as a leading figure in his field. His work not only bridges the gap between traditional and modern medicine but also sets a foundation for transformative discoveries that will benefit patients worldwide.

Top Notable Publications:

Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice

Authors: Qian-Qian Chen

Journal: Advanced Science

Year: 2024

DOI: 10.1002/advs.202406936

Neuraminidase 1 is a Driver of Experimental Cardiac Hypertrophy

Authors: Qian-Qian Chen

Journal: European Heart Journal

Year: 2021

DOI: 10.1093/eurheartj/ehab347

Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases

Authors: Qian-Qian Chen

Journal: The American Journal of Chinese Medicine

Year: 2021

DOI: 10.1142/s0192415x21500403

PMID: 33827385

Untargeted Metabolomics and Lipidomics Uncovering the Cardioprotective Effects of Huanglian Jiedu Decoction on Pathological Cardiac Hypertrophy and Remodeling

Authors: Qian-Qian Chen

Journal: Journal of Ethnopharmacology

Year: 2020

DOI: 10.1016/j.jep.2020.113646

PMID: 33264659

Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

Authors: Qian-Qian Chen

Journal: Circulation

Year: 2017

DOI: 10.1161/circulationaha.117.031139

PMID: 29212895